
Sign up to save your podcasts
Or
Send us a text
Nick Jikomes talks to Dr. Nathan Price, who has a Ph.D. in bioengineering and has been faculty at the University of Washington and the Institute of Systems Biology. He was also CEO of a health intelligence startup called Onegevity, which recently merged with Thorne HealthTech, where he is the Chief Science Officer.
Nathan and Nick discussed various topics in personalized medicine, digital phenotyping, and systems biology, including metabolism and blood sugar monitoring, the microbiome and diet, aging and longevity, and more. They discussed the basic biology of these things as well as different emerging technologies related to health monitoring.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
4.8
7373 ratings
Send us a text
Nick Jikomes talks to Dr. Nathan Price, who has a Ph.D. in bioengineering and has been faculty at the University of Washington and the Institute of Systems Biology. He was also CEO of a health intelligence startup called Onegevity, which recently merged with Thorne HealthTech, where he is the Chief Science Officer.
Nathan and Nick discussed various topics in personalized medicine, digital phenotyping, and systems biology, including metabolism and blood sugar monitoring, the microbiome and diet, aging and longevity, and more. They discussed the basic biology of these things as well as different emerging technologies related to health monitoring.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
5,022 Listeners
2,338 Listeners
1,319 Listeners
485 Listeners
652 Listeners
765 Listeners
335 Listeners
1,118 Listeners
907 Listeners
200 Listeners
64 Listeners
100 Listeners
69 Listeners
111 Listeners
0 Listeners